We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $9.59B
1-Year Est. Return 113.36%
This Fund
S&P 500
This Quarter Est. Return
+14.29%
1 Year Est. Return
+113.36%
3 Year Est. Return
+277.48%
5 Year Est. Return
+350.78%
10 Year Est. Return
+2,290.11%
AUM
$2.45B
AUM Growth
+$519M
Cap. Flow
-$118M
Cap. Flow %
-4.81%
Top 10 Hldgs %
32.76%
Holding
158
New
53
Increased
22
Reduced
25
Closed
33

Top Buys

Rank Stock Value
1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$90.2M
2
LH icon
Labcorp
LH
+$65.9M
3
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$53.4M
4
ABBV icon
AbbVie
ABBV
+$51.8M
5
ITMN
INTERMUNE INC
ITMN
+$35.3M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$43.2M
2
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$41.1M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$37.6M
4
GMED icon
Globus Medical
GMED
+$34.2M
5
QCOR
QUESTCOR PHARMA INC
QCOR
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 50.5%
2 Miscellaneous 47.73%
3 Technology 1.21%
4 Financials 0.56%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XTNT icon
126
Xtant Medical Holdings
XTNT
$52.6M
– –
-3,265
Closed -$196K
VIRX
127
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
-1,190
Closed -$1.19M
INFI
128
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-200,000
Closed -$2.76M
KIN
129
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-225,000
Closed -$2.51M
HMSY
130
DELISTED
HMS Holdings Corp.
HMSY
– –
-57,800
Closed -$1.31M
MNTA
131
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-1,136,645
Closed -$20.1M
ECYT
132
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
-111,967
Closed -$1.2M
AET
133
DELISTED
Aetna Inc
AET
– –
-327,000
Closed -$22.4M
CEMP
134
DELISTED
Cempra, Inc.
CEMP
– –
-309,655
Closed -$3.84M
IMRS
135
DELISTED
IMRIS INC COMMON SHARES (CANADA)
IMRS
– –
-192,051
Closed -$305K
CBST
136
CALL
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-1,000,000
Closed -$68.9M
CBST
137
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
– –
-386,282
Closed -$26.6M
ARTC
138
DELISTED
ARTHROCARE CORP
ARTC
– –
-20,000
Closed -$805K
LCAV
139
DELISTED
LCA-VISION INC
LCAV
– –
-730,856
Closed -$2.85M
BEAT
140
DELISTED
BioTelemetry, Inc.
BEAT
– –
-55,000
Closed -$437K
BIND
141
DELISTED
BIND THERAPEUTICS INC
BIND
– –
-256,384
Closed -$3.87M
OREX
142
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-2,169
Closed -$122K
AIRM
143
CALL
DELISTED
Air Methods Corp
AIRM
– –
-125,000
Closed -$7.28M
2 3 4 5
6

Similar funds

OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $9.53B AUM 52.96% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
A
Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Deerfield Management's Q1 2014 Portfolio in Review

As of Q1 2014, Deerfield Management held 158 positions worth $2.45B, up 27% from $1.93B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Deerfield Management withdrew a net $118M in Q1 2014, closing 33 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 48% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Deerfield Management opened a new position in Dicerna Pharmaceuticals, Inc. worth $68.6M.

  • Deerfield Management's largest Q1 2014 buy was Dicerna Pharmaceuticals, Inc.: 2,428,569 shares worth $68.6M.
  • Deerfield Management added most to Insmed in Q1 2014, an estimated $18.3M increase.
  • Deerfield Management's biggest Q1 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $41.1M.
  • Deerfield Management fully exited Humana in Q1 2014, selling an estimated $43.2M.
  • Deerfield Management's ten largest holdings make up 33% of its $2.45B portfolio in Q1 2014.
  • Deerfield Management opened 53 new positions and closed 33 in Q1 2014.
  • Deerfield Management's portfolio value rose 27% quarter-over-quarter to $2.45B.

Based on Deerfield Management's 13F filing for Q1 2014, filed 15 May 2014.